Advertisement
Screener

UFP Technologies, Inc. (UFPT) Increase (Decrease) in Accounts Receivable

2.8 / 5 stars · 68/120 Roast Me

UFP Technologies, Inc. Increase (Decrease) in Accounts Receivable

UFP Technologies, Inc. (UFPT) reported Increase (Decrease) in Accounts Receivable of $30.53 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06

  • UFP Technologies, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $14.81M.
  • UFP Technologies, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $15.71M, a 76.47% increase year-over-year.
  • UFP Technologies, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$2.21M.
  • UFP Technologies, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$1.86M, a 126.13% decline year-over-year.
  • UFP Technologies, Inc. increase (decrease) in accounts receivable for fiscal 2025 was -$5.34M.
  • UFP Technologies, Inc. increase (decrease) in accounts receivable for fiscal 2024 was -$1.22M, a 113.34% decline from fiscal 2023.
  • UFP Technologies, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $9.12M, a 45.90% decline from fiscal 2022.
  • UFP Technologies, Inc. increase (decrease) in accounts receivable for fiscal 2022 was $16.86M, a 117.49% increase from fiscal 2021.
Period endIncrease (Decrease) in Accounts Receivable 3 monthIncrease (Decrease) in Accounts Receivable 6 monthIncrease (Decrease) in Accounts Receivable 9 monthIncrease (Decrease) in Accounts Receivable 12 month
2026-06-30$14.81M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$30.53M
10-Q · filed 2026-08-06
$28.32M
derived: sum of 3 quarters · filed 2026-08-06
$26.45M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$15.71M
10-Q · filed 2026-05-08
$13.50M
derived: sum of 2 quarters · filed 2026-05-08
$11.64M
derived: sum of 3 quarters · filed 2026-05-08
$1.47M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$2.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$4.07M
derived: sum of 2 quarters · filed 2026-02-27
-$14.24M
derived: sum of 3 quarters · filed 2026-08-06
-$5.34M
10-K · filed 2026-02-27
2025-09-30-$1.86M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
-$12.03M
derived: sum of 2 quarters · filed 2026-08-06
-$3.13M
10-Q · filed 2025-11-07
-$7.24M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$10.17M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$1.26M
10-Q · filed 2026-08-06
-$5.37M
derived: sum of 3 quarters · filed 2026-08-06
$1.75M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$8.90M
10-Q · filed 2026-05-08
$4.79M
derived: sum of 2 quarters · filed 2026-05-08
$11.92M
derived: sum of 3 quarters · filed 2026-05-08
$10.81M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31-$4.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$3.01M
derived: sum of 2 quarters · filed 2026-02-27
$1.90M
derived: sum of 3 quarters · filed 2026-02-27
-$1.22M
10-K · filed 2026-02-27
2024-09-30$7.12M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$6.01M
derived: sum of 2 quarters · filed 2025-11-07
$2.89M
10-Q · filed 2025-11-07
$6.23M
derived: sum of 4 quarters · filed 2026-02-27
2024-06-30-$1.11M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11
-$4.23M
10-Q · filed 2025-08-11
-$897.00K
derived: sum of 3 quarters · filed 2026-02-27
-$3.91M
derived: sum of 4 quarters · filed 2026-02-27
2024-03-31-$3.12M
10-Q · filed 2025-05-12
$213.00K
derived: sum of 2 quarters · filed 2026-02-27
-$2.80M
derived: sum of 3 quarters · filed 2026-02-27
$1.14M
derived: sum of 4 quarters · filed 2026-02-27
2023-12-31$3.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$317.00K
derived: sum of 2 quarters · filed 2026-02-27
$4.26M
derived: sum of 3 quarters · filed 2026-02-27
$9.12M
10-K · filed 2026-02-27
2023-09-30-$3.02M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
$928.00K
derived: sum of 2 quarters · filed 2024-11-12
$5.79M
10-Q · filed 2024-11-12
$2.81M
derived: sum of 4 quarters · filed 2025-03-03
2023-06-30$3.94M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
$8.81M
10-Q · filed 2024-08-09
$5.83M
derived: sum of 3 quarters · filed 2025-03-03
$9.31M
derived: sum of 4 quarters · filed 2025-03-03
2023-03-31$4.86M
10-Q · filed 2024-05-10
$1.89M
derived: sum of 2 quarters · filed 2025-03-03
$5.36M
derived: sum of 3 quarters · filed 2025-03-03
$17.26M
derived: sum of 4 quarters · filed 2025-03-03
2022-12-31-$2.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03
$501.00K
derived: sum of 2 quarters · filed 2025-03-03
$12.40M
derived: sum of 3 quarters · filed 2025-03-03
$16.86M
10-K · filed 2025-03-03
2022-09-30$3.48M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$15.37M
derived: sum of 2 quarters · filed 2023-11-09
$19.84M
10-Q · filed 2023-11-09
$21.57M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30$11.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$16.36M
10-Q · filed 2023-08-09
$18.09M
derived: sum of 3 quarters · filed 2024-02-29
$19.32M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31$4.47M
10-Q · filed 2023-05-10
$6.19M
derived: sum of 2 quarters · filed 2024-02-29
$7.43M
derived: sum of 3 quarters · filed 2024-02-29
$8.63M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31$1.73M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-02-29
$2.96M
derived: sum of 2 quarters · filed 2024-02-29
$4.16M
derived: sum of 3 quarters · filed 2024-02-29
$7.75M
10-K · filed 2024-02-29
2021-09-30$1.23M
derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-11-14
$2.44M
derived: sum of 2 quarters · filed 2022-11-14
$6.03M
10-Q/A · filed 2022-11-14
$5.09M
derived: sum of 4 quarters · filed 2023-03-16
2021-06-30$1.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$4.79M
10-Q · filed 2022-08-09
$3.86M
derived: sum of 3 quarters · filed 2023-03-16
$3.95M
derived: sum of 4 quarters · filed 2023-03-16
2021-03-31$3.59M
10-Q · filed 2022-05-10
$2.65M
derived: sum of 2 quarters · filed 2023-03-16
$2.75M
derived: sum of 3 quarters · filed 2023-03-16
$569.00K
derived: sum of 4 quarters · filed 2023-03-16
2020-12-31-$936.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
-$843.00K
derived: sum of 2 quarters · filed 2023-03-16
-$3.02M
derived: sum of 3 quarters · filed 2023-03-16
-$2.22M
10-K · filed 2023-03-16
2020-09-30$93.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
-$2.08M
derived: sum of 2 quarters · filed 2021-11-05
-$1.28M
10-Q · filed 2021-11-05
-$1.43M
derived: sum of 4 quarters · filed 2022-03-14
2020-06-30-$2.18M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06
-$1.38M
10-Q · filed 2021-08-06
-$1.52M
derived: sum of 3 quarters · filed 2022-03-14
-$3.41M
derived: sum of 4 quarters · filed 2022-03-14
2020-03-31$801.00K
10-Q · filed 2021-05-07
$653.00K
derived: sum of 2 quarters · filed 2022-03-14
-$1.23M
derived: sum of 3 quarters · filed 2022-03-14
-$323.00K
derived: sum of 4 quarters · filed 2022-03-14
2019-12-31-$148.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14
-$2.03M
derived: sum of 2 quarters · filed 2022-03-14
-$1.12M
derived: sum of 3 quarters · filed 2022-03-14
$327.00K
10-K · filed 2022-03-14
2019-09-30-$1.89M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
-$976.00K
derived: sum of 2 quarters · filed 2020-11-06
$475.00K
10-Q · filed 2020-11-06
-$1.35M
derived: sum of 4 quarters · filed 2021-03-12
2019-06-30$909.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07
$2.36M
10-Q · filed 2020-08-07
$537.00K
derived: sum of 3 quarters · filed 2021-03-12
2019-03-31$1.45M
10-Q · filed 2020-05-08
-$372.00K
derived: sum of 2 quarters · filed 2021-03-12
2018-12-31-$1.82M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
$2.56M
10-K · filed 2021-03-12
2018-09-30$4.38M
10-Q · filed 2019-11-08
2017-12-31$132.00K
10-K · filed 2020-03-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
NovoCure Ltd (NVCR)$1.886B-11.87
LEMAITRE VASCULAR INC (LMAT)United States$1.848B33.37
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
AtriCure, Inc. (ATRC)United States$3.089B
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57